TY  - GEN
AU  - O'Flaherty,E
AU  - Cebon,J
AU  - Grigg,A P
TI  - Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensity
SN  - 1042-8194
PY  - 1998///0129
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Blood Preservation
KW  - Cell Count
KW  - Cell Survival
KW  - drug effects
KW  - Cells, Cultured
KW  - Cryopreservation
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Epirubicin
KW  - Erythroid Precursor Cells
KW  - Granulocyte Colony-Stimulating Factor
KW  - Hematopoietic Stem Cells
KW  - Humans
KW  - Lymphoma, Non-Hodgkin
KW  - drug therapy
KW  - Phlebotomy
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3109/10428199709059689
ER  -